IL1B and atherosclerosis: Targeting IL-1β signaling reduces cardiovascular risk in atherosclerotic patients45 and AIM2 has recently been identified as an essential mediator of atherosclerosis driven by clonal hematopoiesis induced by the common Jak2V617F mutation.8